Arcadia Biosciences (RKDA) Shares Outstanding (2014 - 2025)

Arcadia Biosciences' Shares Outstanding (Entity) history runs 11 years deep, the most recent figure standing at $1.4 million for Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 0.6% year-over-year to $1.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.4 million (up 0.6% YoY) and the FY2025 annual result came in at $1.4 million, up 0.6% from the prior year.
• Shares Outstanding (Entity) was $1.4 million for Q4 2025 at Arcadia Biosciences, roughly flat from $1.4 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $1.4 million in Q4 2025 and bottomed at $533406.0 in Q1 2021.
• A 5-year average of $991508.8 and a median of $1.1 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) jumped 146.55% — and 2022, when it climbed 0.11%.
• Arcadia Biosciences' Shares Outstanding (Entity) stood at $554606.0 in 2021, then rose by 11.08% to $616079.0 in 2022, then soared by 108.63% to $1.3 million in 2023, then advanced by 6.19% to $1.4 million in 2024, then increased by 0.6% to $1.4 million in 2025.
• Business Quant data shows RKDA's Shares Outstanding (Entity) at $1.4 million in Q4 2025, $1.4 million in Q3 2025, and $1.4 million in Q2 2025.